Table 1 Patient characteristics
Characteristic | No. of patients | % |
|---|---|---|
Patients evaluable | 70 | 100 |
Age, years | ||
Median (range) | 65 (32–75) | |
Sex | ||
Male | 41 | 58.5 |
Female | 29 | 41.5 |
Response to prior chemotherapy | ||
Yes | 44 | 63 |
No | 26 | 37 |
Status of primary tumor | ||
Resected | 25 | 36 |
Unresected | 45 | 64 |
Tumor histology | ||
Diffuse | 33 | 47.2 |
Intestinal | 29 | 41.4 |
Unknown | 8 | 11.4 |
ECOG PS | ||
0 | 10 | 14.5 |
1 | 40 | 57 |
2 | 20 | 28.5 |
Number of metastatic sites | ||
1 | 17 | 24 |
2 | 32 | 46 |
3 | 21 | 30 |
Site of metastases | ||
Liver | 48 | 68.5 |
Nodes | 41 | 58.5 |
Peritoneum | 41 | 58.5 |
Lung | 13 | 18.5 |
Bone | 6 | 8.5 |
PFS under first-line chemotherapy | ||
≥ 6 months | 42 | 60 |
< 6 months | 28 | 40 |
Chemotherapy-free interval | ||
> 3 months | 38 | 54 |
< 3 months | 32 | 46 |